Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").

Fedex Securities Pvt Ltd, Manager to the Offer, has submitted a Draft Letter of Offer for an open offer to acquire up to 2,346,250 equity shares, representing 26.00% of Parmax Pharma Ltd's expanded voting capital, from its public shareholders. The offer is made by Dhiren Chandulal Shah and Sunil Chinubhai Shah, along with ten Persons Acting in Concert (PACs), at a price of ₹42.80 per equity share, in compliance with SEBI (SAST) Regulations, 2011.